LAUSANNE, Switzerland & PALO ALTO, Calif.–(BUSINESS WIRE)–Polares Medical SA (“Polares”), a clinical-stage structural heart company developing the MRace Posterior Leaflet Replacement (PLR) system for mitral regurgitation (MR), today announced the closing of a $50 million Series C financing. The oversubscribed financing was achieved with strong participations from DC Global Ventures, Lumination Partners, existing investors, and a new strategic investor. Polares is focused on the large and grow
Tag: Polares Medical
Polares Medical Closes a $25M Financing to Enter Clinical Validation
Lausanne, Switzerland and Palo Alto, USA, July 17, 2018 / B3C newswire / — Polares Medical SA, a preclinical stage medical technology company focused on the development of a unique trans-catheter mitral valve hemi-replacement system to treat patients suffering from mitral regurgitation (MR), announced today the closing of a $25 million […]



